Double-negative feedback loop between MicroRNA-422a and forkhead box (FOX)G1/Q1/E1 regulates hepatocellular carcinoma tumor growth and metastasis

Hepatology

Volumn 61, Issue 2, 2015, Pages 561-573

  Zhang, Jin ^a   Yang, Yun ^a   Yang, Tian ^a   Yuan, Shengxian ^a   Wang, Ruoyu ^a   Pan, Zeya ^a   Yang, Yuan ^a   Huang, Gang ^a   Gu, Fangming ^a   Jiang, Beige ^a   Lin, Chuan ^a   Zhou, Weiping ^a,b  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b National Innovation Alliance for Hepatitis and Liver Cancer   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DIETHYLNITROSAMINE; FORKHEAD TRANSCRIPTION FACTOR; LENTIVIRUS VECTOR; MICRORNA; MICRORNA 422A; SHORT HAIRPIN RNA; TRANSCRIPTION FACTOR FOXE1; TRANSCRIPTION FACTOR FOXG1; TRANSCRIPTION FACTOR FOXQ1; UNCLASSIFIED DRUG; MIRN422 MICRORNA, HUMAN;

3' UNTRANSLATED REGION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GENE THERAPY; CANCER GROWTH; CANCER INHIBITION; CARCINOMA CELL; CELL MIGRATION; CELL PROLIFERATION; COLONY FORMATION; CONTROLLED STUDY; DOWN REGULATION; GENE OVEREXPRESSION; HEPATOCELLULAR CARCINOMA CELL LINE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER METASTASIS; MICROARRAY ANALYSIS; MOUSE; NEGATIVE FEEDBACK; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TUMOR MODEL; TUMOR XENOGRAFT; ADULT; ANIMAL; BAGG ALBINO MOUSE; CARCINOGENESIS; CASE CONTROL STUDY; CELL MOTION; EXPERIMENTAL LIVER NEOPLASM; FEMALE; GENE EXPRESSION REGULATION; GENE SILENCING; GENETICS; HEPG2 CELL LINE; MALE; METABOLISM; METASTASIS; MIDDLE AGED; YOUNG ADULT;

ADULT; ANIMALS; CARCINOGENESIS; CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; CELL MOVEMENT; CELL PROLIFERATION; DOWN-REGULATION; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HEP G2 CELLS; HUMANS; LIVER NEOPLASMS, EXPERIMENTAL; MALE; MICE, INBRED BALB C; MICRORNAS; MIDDLE AGED; NEOPLASM METASTASIS; YOUNG ADULT;

EID: 84921473125     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.27491     Document Type: Article

References (22)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011;61:69-90.
2. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, et al. MicroRNA expression profiles classify human cancers. Nature 2005;435:834-838.
3. Finch ML, Marquardt JU, Yeoh GC, Callus BA. Regulation of microRNAs and their role in liver development, regeneration and disease. Int J Biochem Cell Biol 2014;54C:288-303.
4. Sepramaniam S, Tan JR, Tan KS, DeSilva DA, Tavintharan S, Woon FP, et al. Circulating microRNAs as biomarkers of acute stroke. Int J Mol Sci 2014;15:1418-1432.
5. Molina-Pinelo S, Gutierrez G, Pastor MD, Hergueta M, Moreno-Bueno G, Garcia-Carbonero R, et al. MicroRNA-dependent regulation of transcription in non-small cell lung cancer. PLoS One 2014;9:e90524.
6. Cao Z, Moore BT, Wang Y, Peng XH, Lappe JM, Recker RR, et al. MiR-422a as a potential cellular microRNA biomarker for postmenopausal osteoporosis. PLoS One 2014;9:e97098.
7. Faltejskova P, Svoboda M, Srutova K, Mlcochova J, Besse A, Nekvindova J, et al. Identification and functional screening of microRNAs highly deregulated in colorectal cancer. J Cell Mol Med 2012;16:2655-2666.
8. Wang Y, Lee AT, Ma JZ, Wang J, Ren J, Yang Y, et al. Profiling microRNA expression in hepatocellular carcinoma reveals microRNA-224 up-regulation and apoptosis inhibitor-5 as a microRNA-224-specific target. J Biol Chem 2008;283:13205-13215.
9. Wang Y, Toh HC, Chow P, Chung AY, Meyers DJ, Cole PA, et al. MicroRNA-224 is up-regulated in hepatocellular carcinoma through epigenetic mechanisms. FASEB J 2012;26:3032-3041.
10. Zheng Q, Sheng Q, Jiang C, Shu J, Chen J, Nie Z, et al. MicroRNA-452 promotes tumorigenesis in hepatocellular carcinoma by targeting cyclin-dependent kinase inhibitor 1B. Mol Cell Biochem 2014.
11. Vauthey JN, Lauwers GY, Esnaola NF, Do KA, Belghiti J, Mirza N, et al. Simplified staging for hepatocellular carcinoma. J Clin Oncol 2002;20:1527-1536.
12. Greene FL, Page DL, Fleming ID, Fritz AG, Balch CM, Haller DG. American Joint Committee on cancer staging manual, 6th ed. New York: Springer; 2002:14.
13. Siegel SR, Mackenzie J, Chaplin G, Jablonski NG, Griffiths L. Circulating microRNAs involved in multiple sclerosis. Mol Biol Rep 2012;39:6219-6225.
14. Bidzhekov K, Gan L, Denecke B, Rostalsky A, Hristov M, Koeppel TA, et al. microRNA expression signatures and parallels between monocyte subsets and atherosclerotic plaque in humans. Thromb Haemost 2012;107:619-625.
15. Wang P, Fu T, Wang X, Zhu W. [Primary, study of miRNA expression patterns in laryngeal carcinoma by microarray.] Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2010;24:535-538.
16. Liang S, Chen L, Huang H, Zhi D. The experimental study of miRNA in pituitary adenomas. Turk Neurosurg 2013;23:721-727.
17. Omura T, Shimada Y, Nagata T, Okumura T, Fukuoka J, Yamagishi F, et al. Relapse-associated microRNA in gastric cancer patients after S-1 adjuvant chemotherapy. Oncol Rep 2014;31:613-618.
18. Xia L, Huang W, Tian D, Zhang L, Qi X, Chen Z, et al. Forkhead box Q1 promotes hepatocellular carcinoma metastasis by transactivating ZEB2 and VersicanV1 expression. Hepatology 2014;59:958-973.
19. Verginelli F, Perin A, Dali R, Fung KH, Lo R, Longatti P, et al. Transcription factors FOXG1 and Groucho/TLE promote glioblastoma growth. Nat Commun 2013;4:2956.
20. Fan Y, Ding Z, Yang Z, Deng X, Kang J, Wu B, et al. Expression and clinical significance of FOXE1 in papillary thyroid carcinoma. Mol Med Rep 2013;8:123-127.
21. Zhu H, Xi Q, Liu L, Wang J, Gu M. Quantitative assessment of common genetic variants on FOXE1 and differentiated thyroid cancer risk. PLoS One 2014;9:e87332.
22. Kang J, Deng XZ, Fan YB, Wu B. Relationships of FOXE1 and ATM genetic polymorphisms with papillary thyroid carcinoma risk: a meta-analysis. Tumour Biol 2014;35:7085-7096.